SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure amid scrutiny of CEO Jensen Huangs relationship with an alleged Chinese spy and reports that a network linked to her facilitated shipments of Nvidia hardware to Chinese companies; the allegations remain disputed, and their implications for export controls and Huangs leadership are uncertain. Traders are split between seeing the controversy as a serious governance and business risk and treating the selloff as an overreaction given Nvidias underlying AI-chip demand.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A disappointing Q3 report, with a surprise loss, weaker margins, a sequential subscriber decline and reduced profit guidance, is driving HIMSs sharp selloff. Traders are debating whether the results signal deeper execution and profitability problems or a buying opportunity, with some bulls pointing to the planned Peptides+ launch and Andrew Hubermans board role as potential growth drivers.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,110,071. The last known price of Bitcoin is 74,895.40905656 USD and is down -0.28 over the last 24 hours. It is currently trading on 12776 active market(s) with $26,892,693,016.04 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins decline is being tied to hotter-than-expected U.S. inflation and rising expectations of further Fed rate hikes, with traders also citing liquidations of leveraged long positions. The community is split between viewing the selloff as a buying opportunity and warning of deeper losses, while debating Bitcoins role as an inflation hedge.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTDs quarterly earnings beat and stronger-than-expected outlook sparked a sharp rally that quickly faded as traders questioned the quality and durability of growth, including the effects of one-off revenue tailwinds and managements cautious tone. Bulls point to the results, buyback authorization and potential short covering, while bears focus on revenue contraction, margins and doubts about managements follow-through.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,203,846.69715353. The last known price of Ethereum is 2,121.02700944 USD and is down -0.91 over the last 24 hours. It is currently trading on 14303 active market(s) with $13,174,532,202.61 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a sharp crypto-wide selloff, with traders pointing to hot inflation data, renewed Fed rate-hike concerns and leveraged-long liquidations as pressure on risk assets. The conversation is heavily bearish, with some expecting further declines, while others view the weakness as a buying opportunity and continue accumulating.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.09792366 USD and is down -1.80 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,759,095,442.76 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is drawing attention amid a steep pullback alongside a broader crypto selloff, with traders citing Bitcoin weakness, inflation and interest-rate concerns, and liquidations as pressure on risk assets. The debate centers on whether the decline is capitulation near a key round-number support or a sign of further weakness: some holders are buying the dip and pointing to whale accumulation, while others question XRPs demand and Ripples role.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,957,873.22986632. The last known price of Zcash is 1,170.00468254 USD and is down -4.93 over the last 24 hours. It is currently trading on 669 active market(s) with $1,123,501,581.28 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention after a sharp selloff amid broader crypto weakness and reports of leveraged long liquidations, though traders also question why the drop was so abrupt. The reaction is split between bearish calls for further losses and buyers treating the pullback as a dip, with some attributing pressure to the wider market rather than a Zcash-specific catalyst.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention after management said GTA VI preorders are far above expectations, boosting optimism ahead of the launch despite a quarterly bookings shortfall and unchanged bookings outlook. Bulls point to blockbuster sales and future online monetization, while skeptics argue the hype may already be priced in and warn of a sell-the-news reaction.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines earnings-driven selloff is dominating discussion: despite beating revenue expectations and raising its sales outlook, margin compression and unchanged profit guidance fueled concerns that growth is not translating into stronger profitability, with debt adding to the caution. Bulls call the drop an overreaction to investment spending and a strong top-line report, while bears view the margin pressure as a warning sign.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta is drawing attention after a strong quarterly earnings beat and raised guidance, with traders debating the results against sharp post-report swings and a quick recovery. Bulls view the dip as a buying opportunity, while skeptics point to sell-the-news pressure and concerns such as stock-based compensation.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Crude Oil Moves Higher; US Factory Orders Rise In July

U.S. stocks rose mid-session, led by materials; factory orders beat estimates. Linkhome, Purple Biotech and GitLab surged, while Tscan and Credo fell.read more...

Purple Biotech’s Patent Win Adds Armor to a Bigger Oncology Bet

Purple Biotech (NASDAQ:PPBT) just strengthened one of the most important pieces of its oncology strategy: the intellectual-property foundation behind CAPTN-3, its modular platform for conditionally activated tri-specific antibodies designed to attack tumors while potentially limiting systemic immune toxicity.

Purple Biotech CEO Gil Efron To Step Down For Health Reasons

(RTTNews) - Purple Biotech Ltd. (PPBT), a clinical-stage pharmaceutical company, Friday announced that its Chief Executive Officer, Gil Efron will step down from his role in August, due to health...

Purple Biotech Shares Soar 92% On Breakthrough For Experimental Cancer Drug

Equity

Purple Biotech's Shrinking Losses Keep Retail Sentiment In The Green, But Other Pressures Loom

As of Dec. 31, 2024, Purple Biotech had $8.2 million in cash and short-term deposits, which it expects will be sufficient to fund operations into mid-2026.

News Movers: Yesterday’s Hottest News That Could Move the Needle Today

Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks

Purple Biotech Stock Hits Nearly 2-Month High On Cancer Drug Trial Success: Retail Thrilled

CM24 targets CEACAM1, a multi-functional membrane glycoprotein that plays a critical role in tumor invasiveness, metastasis, and immune evasion.

Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3. The CM24 is a humanized monoclonal antibody that blocks CEACAM1, which supports tumor immune evasion and survival through multiple pathways. The NT219 is a dual inhibitor, novel small molecule that simultaneously targets IRS1/2 and STAT3. The CAPTN-3, a preclinical platform of conditionally activated tri-specific antibodies, which engage both T cells and NK cells to induce a strong, localized immune response within the tumor microenvironment. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.

Purple Biotech Ltd - ADR

Bullish Sentiment

<ul class="summary-bullets"><li>Purple said that it has achieved a commercially viable yield for IM1240, positioning the program competitively for future development.</li><li>The company now plans to make an Investigational New Drug (IND) submission to the U.S. Food and Drug Administration in 2026, paving the way for its first-in-human clinical trials. &nbsp;</li></ul>NASDAQ-listed shares of Purple Biotech Ltd. (PPBT) soared 92% on Wednesday morning after the company achieved a manufacturing milestone for its experimental cancer drug IM1240.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/29/3176325/0/en/Purple-Biotech-Achieves-Manufacturing-Milestone-for-IM1240-a-Tri-Specific-Antibody-from-the-CAPTN-3-Platform.html">said</a> that it has achieved a commercially viable yield for IM1240, positioning the program competitively for future development.IM1240 is a tri-specific antibody from the CAPTN-3 preclinical platform targeting the antigen 5T4, which is expressed in a variety of solid tumors and is associated with advanced disease, increased invasiveness, and poor clinical outcomes. The company now plans to make an Investigational New Drug (IND) submission to the U.S. Food and Drug Administration in 2026, paving the way for its first-in-human clinical trials.<blockquote>“Drawing on my decades of experience in antibody manufacturing, producing a tri-specific protein such as IM1240 at high yield and purity was perceived as a significant challenge-one that I’m pleased to have successfully mastered.”&nbsp; Michael Schickler, Head of Clinical and Regulatory Affairs, Purple Biotech</blockquote><h2 class="st-heading-2">Window To Maintain Listing Standards&nbsp;</h2>Earlier this month, Purple Biotech received a letter from the Nasdaq, notifying the company that it is not in compliance with the minimum bid price requirement for continued listing on the bourse.&nbsp;The company now has until April 14, 2026, to regain compliance with the minimum bid price requirement.<h2 class="st-heading-2">What Is Retail Thinking?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/PPBT">PPBT stock</a> jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.A Stocktwits user now expects a dilution, provided the company needs money.<stembedurl>https://stocktwits.com/Stocksavior14/message/634120144</stembedurl>Another, however, believes that the stock will yield real profits in time.<stembedurl>https://stocktwits.com/McTradesPharmD_MBA/message/634121569</stembedurl>PPBT stock is down by 76% this year and by about 68% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-partners-with-walmart-to-expand-access-to-popular-weight-loss-drug/cLGZNj7R3wE">Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Purple said that it has achieved a commercially viable yield for IM1240, positioning the program competitively for future development.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.23
Prev Close	$1.34
Open	$1.30
Dividend Yield	0.00%
50-Day Moving Average	$1.42
Beta	0.25
Avg. Volume	23,165.27
PE Ratio	-0.05

52-Week High	$8.90
52-Week Low	$0.91
Market Capitalization	$2.17M
EPS (Annual)	-$55.40
Price to Book	0.18
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

PPBT Fundamentals